chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Hypoaesthesia, Injection site hypoaesthesia, Injection site reaction, Paraesthesia
Clinical narrative: Numbness and Tingling at injection site and then it began to spread down the arm stopping at the wrist and then up into the shoulder. Patient came into office for evaluation on 08/26/2015, Doctor evaluated the patient and treatment was observation and consultation with a neurologist.
Age: 22.0
Sex: F
Vaccine: MENB
Symptoms: Feeling of body temperature change, Nausea, Pain, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer reporting for herself. A 22-year-old female patient received second dose of TRUMENBA, via an unspecified route of administration, on 13May2015 at 04:00 PM, at single dose, due to Meningitis outbreak at her university. Medical history and concomitant medications were none. The patient experienced low fever for 8 hours, nausea, like body aches for 2 hours, like hot and cold flashes for 2 hours. The patient was admitted to hospital on 13May2015 4 hours after receiving the vaccine shot. Therapeutic measures were taken as a result of low fever and included treatment with TYLENOL and ADVIL. No treatment was received for like body aches and like hot and cold flashes. No lab tests done. The final outcome of the events was recovered. Follow-up (17Aug2015): new information received from the same contactable consumer includes: seriousness, events details. Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: MEN
Symptoms: CSF shunt operation, Meningitis
Clinical narrative: Initial unsolicited report received from a consumer (patient parent) on 18-Aug-2015. A female patient (age was not reported), whose medical history and concomitant medications were not provided had received a dose of Meningococcal vaccine (dose details, batch number, route of administration and site of administration were not reported) on an unspecified date. On an unspecified date, 14 days post-vaccination, the patient developed meningitis. Laboratory investigations and corrective treatments were not provided. At the time of this report, patient was recovered from the above mentioned event on an unspecified date however she had a shunt. Upon internal review, this case was considered serious due to important medical event: meningitis. Documents held by sender: none.
Age: 14.0
Sex: M
Vaccine: MNQ
Symptoms: Amnesia, Asthenia, Blindness transient, Dizziness, Headache
Clinical narrative: Based on additional information received on 14 August 2015, this case initially considered as non serious was upgraded to serious due to important medical event Upper Respiratory Infection. Based on additional information received on 14 August 2015, this case became medically confirm. Initial unsolicited report received from a consumer (patient parent) on 5 June 2015. A 14-year-old male patient, whose medical history and concomitant medications were not reported, had received a dose of MENACTRA (batch number, route and site of administration were not reported) on 2 June 2015. Illness at the time of vaccination was not reported. On 3 June 2015, one day after vaccination, the patient experienced swelling and pain at injection site, sore throat, lightheadedness and during the afternoon had an episode in which his vision went black while walking from one room to another and he did not remember going from the first to the second room. On 4 June 2015, patient continued to experience same symptoms with addition of headache, weakness, dizziness, flu like symptoms, and fever up to 100.4 degree Fahrenheit. Laboratory investigations were not reported. The patient was treated with ADVIL and TYLENOL cold medicine. As of 5 June 2015, the patient was not recovered from the events. Documents held by sender: none. Follow up report received from a healthcare professional (Physician) on 14 August 2015. A 14-year-old-male-patient received 0.5 ml dose of MENACTRA (Batch number U4798AA) in right arm on 2 June 2015. Illness at the time of vaccination and preexisting physician diagnosed allergies, birth defects, medical condition was reported as none. Any other vaccination within four week prior to 2 June 2015 was reported as none. It was also reported that the patient did not receive any other medication. Adverse event following prior vaccination was reported as none. On 3 June 2015, one day after vaccination "reported as two days later" the patient experienced URI (upper respiratory infection). It was reported that there was no residual effect and the patient started with URI "around day 3-4". Other laboratory tests were reported as none. On an unspecified date, about 1 week after onset the patient was recovered from the URI. Upon medical review, the case was considered as serious due to important medical event: URI (upper respiratory infection).
Age: 14.0
Sex: M
Vaccine: MNQ
Symptoms: Influenza like illness, Injection site pain, Injection site swelling, Oropharyngeal pain, Pyrexia
Clinical narrative: Based on additional information received on 14 August 2015, this case initially considered as non serious was upgraded to serious due to important medical event Upper Respiratory Infection. Based on additional information received on 14 August 2015, this case became medically confirm. Initial unsolicited report received from a consumer (patient parent) on 5 June 2015. A 14-year-old male patient, whose medical history and concomitant medications were not reported, had received a dose of MENACTRA (batch number, route and site of administration were not reported) on 2 June 2015. Illness at the time of vaccination was not reported. On 3 June 2015, one day after vaccination, the patient experienced swelling and pain at injection site, sore throat, lightheadedness and during the afternoon had an episode in which his vision went black while walking from one room to another and he did not remember going from the first to the second room. On 4 June 2015, patient continued to experience same symptoms with addition of headache, weakness, dizziness, flu like symptoms, and fever up to 100.4 degree Fahrenheit. Laboratory investigations were not reported. The patient was treated with ADVIL and TYLENOL cold medicine. As of 5 June 2015, the patient was not recovered from the events. Documents held by sender: none. Follow up report received from a healthcare professional (Physician) on 14 August 2015. A 14-year-old-male-patient received 0.5 ml dose of MENACTRA (Batch number U4798AA) in right arm on 2 June 2015. Illness at the time of vaccination and preexisting physician diagnosed allergies, birth defects, medical condition was reported as none. Any other vaccination within four week prior to 2 June 2015 was reported as none. It was also reported that the patient did not receive any other medication. Adverse event following prior vaccination was reported as none. On 3 June 2015, one day after vaccination "reported as two days later" the patient experienced URI (upper respiratory infection). It was reported that there was no residual effect and the patient started with URI "around day 3-4". Other laboratory tests were reported as none. On an unspecified date, about 1 week after onset the patient was recovered from the URI. Upon medical review, the case was considered as serious due to important medical event: URI (upper respiratory infection).
Age: 14.0
Sex: M
Vaccine: MNQ
Symptoms: Upper respiratory tract infection
Clinical narrative: Based on additional information received on 14 August 2015, this case initially considered as non serious was upgraded to serious due to important medical event Upper Respiratory Infection. Based on additional information received on 14 August 2015, this case became medically confirm. Initial unsolicited report received from a consumer (patient parent) on 5 June 2015. A 14-year-old male patient, whose medical history and concomitant medications were not reported, had received a dose of MENACTRA (batch number, route and site of administration were not reported) on 2 June 2015. Illness at the time of vaccination was not reported. On 3 June 2015, one day after vaccination, the patient experienced swelling and pain at injection site, sore throat, lightheadedness and during the afternoon had an episode in which his vision went black while walking from one room to another and he did not remember going from the first to the second room. On 4 June 2015, patient continued to experience same symptoms with addition of headache, weakness, dizziness, flu like symptoms, and fever up to 100.4 degree Fahrenheit. Laboratory investigations were not reported. The patient was treated with ADVIL and TYLENOL cold medicine. As of 5 June 2015, the patient was not recovered from the events. Documents held by sender: none. Follow up report received from a healthcare professional (Physician) on 14 August 2015. A 14-year-old-male-patient received 0.5 ml dose of MENACTRA (Batch number U4798AA) in right arm on 2 June 2015. Illness at the time of vaccination and preexisting physician diagnosed allergies, birth defects, medical condition was reported as none. Any other vaccination within four week prior to 2 June 2015 was reported as none. It was also reported that the patient did not receive any other medication. Adverse event following prior vaccination was reported as none. On 3 June 2015, one day after vaccination "reported as two days later" the patient experienced URI (upper respiratory infection). It was reported that there was no residual effect and the patient started with URI "around day 3-4". Other laboratory tests were reported as none. On an unspecified date, about 1 week after onset the patient was recovered from the URI. Upon medical review, the case was considered as serious due to important medical event: URI (upper respiratory infection).
Age: 18.0
Sex: F
Vaccine: FLU3, HPV4, HPV4, FLUX, HPV4
Symptoms: Blood culture, Culture urine, Dyskinesia, Echocardiogram normal, Electroencephalogram normal
Clinical narrative: 3 days of intermittent twitching/jerking movement of arms, head and neck, epsiodes approx. 20-40 min in duration. Involved hyperventilation, improved with . Admitted 8/22-24. No meds given.
Age: 18.0
Sex: F
Vaccine: FLU3, HPV4, HPV4, FLUX, HPV4
Symptoms: Full blood count, Hyperventilation, Induration, Malaria antibody test, Metabolic function test
Clinical narrative: 3 days of intermittent twitching/jerking movement of arms, head and neck, epsiodes approx. 20-40 min in duration. Involved hyperventilation, improved with . Admitted 8/22-24. No meds given.
Age: 18.0
Sex: F
Vaccine: FLU3, HPV4, HPV4, FLUX, HPV4
Symptoms: Muscle twitching, Nuclear magnetic resonance imaging normal, Polymerase chain reaction, Urine analysis
Clinical narrative: 3 days of intermittent twitching/jerking movement of arms, head and neck, epsiodes approx. 20-40 min in duration. Involved hyperventilation, improved with . Admitted 8/22-24. No meds given.
Age: 18.0
Sex: F
Vaccine: FLU3, HPV4, HPV4, FLUX, HPV4
Symptoms: Blood culture negative, Borrelia test negative, Culture urine negative, Echocardiogram normal, Electroencephalogram normal
Clinical narrative: 3 days of intermittent twitching/jerking movement of arms, head and neck, epsiodes approx. 20-40 min in duration. Involved hyperventilation, improved with . Admitted 8/22-24. No meds given.
Age: 18.0
Sex: F
Vaccine: FLU3, HPV4, HPV4, FLUX, HPV4
Symptoms: Full blood count normal, Generalised tonic-clonic seizure, Laboratory test normal, Metabolic function test normal, Nuclear magnetic resonance imaging normal
Clinical narrative: 3 days of intermittent twitching/jerking movement of arms, head and neck, epsiodes approx. 20-40 min in duration. Involved hyperventilation, improved with . Admitted 8/22-24. No meds given.
Age: 18.0
Sex: F
Vaccine: FLU3, HPV4, HPV4, FLUX, HPV4
Symptoms: Polymerase chain reaction, Smear site unspecified normal, Urine analysis normal
Clinical narrative: 3 days of intermittent twitching/jerking movement of arms, head and neck, epsiodes approx. 20-40 min in duration. Involved hyperventilation, improved with . Admitted 8/22-24. No meds given.
Age: 18.0
Sex: F
Vaccine: FLU3, HPV4, HPV4, FLUX, HPV4
Symptoms: Autonomic nervous system imbalance, Blood test, Dyspnoea, Electrocardiogram ambulatory abnormal, Hypotension
Clinical narrative: 3 days of intermittent twitching/jerking movement of arms, head and neck, epsiodes approx. 20-40 min in duration. Involved hyperventilation, improved with . Admitted 8/22-24. No meds given.
Age: 18.0
Sex: F
Vaccine: FLU3, HPV4, HPV4, FLUX, HPV4
Symptoms: Psychogenic seizure, Tachycardia, Tilt table test, Tonic clonic movements
Clinical narrative: 3 days of intermittent twitching/jerking movement of arms, head and neck, epsiodes approx. 20-40 min in duration. Involved hyperventilation, improved with . Admitted 8/22-24. No meds given.
Age: 61.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Asthenia, Fatigue, Headache, Nausea, Pain
Clinical narrative: Diffuse arm swelling, pain, red rash, weakness, fatigue, nausea, fever, headache.
Age: 61.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Peripheral swelling, Pyrexia, Rash erythematous
Clinical narrative: Diffuse arm swelling, pain, red rash, weakness, fatigue, nausea, fever, headache.
Age: 0.43
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Conversion disorder, Pyrexia, Screaming, Sputum discoloured, Vomiting
Clinical narrative: Hysterical screaming for four hours, fever, vomiting green frothy mucous. Not relieved by Tylenol or ibuprofen.
Age: 1.28
Sex: F
Vaccine: MMR, VARCEL, MMR, VARCEL
Symptoms: Lymphadenopathy
Clinical narrative: Prominent bilateral inguinal lymphadenopathy.
Age: 1.28
Sex: F
Vaccine: MMR, VARCEL, MMR, VARCEL
Symptoms: Injection site reaction
Clinical narrative: Prominent bilateral inguinal lymphadenopathy.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Lymph node pain, Pruritus
Clinical narrative: Erythema and swelling of right arm injection site; pruritis and right axilla node tenderness.
Age: 0.37
Sex: M
Vaccine: DTAP, RV1
Symptoms: Injection site erythema, Injection site swelling, Irritability
Clinical narrative: Bump and redness the size of a dime at the injection site on the Left thigh. Patient was also fussy.
Age: 36.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Furuncle, Headache, Hypoaesthesia, Injection site abscess, Injection site erythema
Clinical narrative: Pt reported redness, swelling and itching at injection site (posterior RUE). He states he has also develeoped an "boil". Pt was out of town when reaction was reported to our office 08/25/15, so he sent in photos of the reaction. Initial photo revealed small area of swelling, no pustule or vesicle formation with surrounding erythema. He drew pen marks at the edge of redness and later photo revealed spread of erythema in addition to what appears to be small abscess. He c/o of low grade fever 99-101.1 for which he used Paracetamol. Other c/o included headache, nausea without vomiting and right hand numbness. When I spoke to the pt 08/26/15 I told him I would call in a prescription for the skin infection. He will be seen in our office when he returns from out of town 08/28/15. He states all symptoms other are improved over last two days.
Age: 36.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Injection site pruritus, Injection site swelling, Nausea, Pyrexia, Skin infection
Clinical narrative: Pt reported redness, swelling and itching at injection site (posterior RUE). He states he has also develeoped an "boil". Pt was out of town when reaction was reported to our office 08/25/15, so he sent in photos of the reaction. Initial photo revealed small area of swelling, no pustule or vesicle formation with surrounding erythema. He drew pen marks at the edge of redness and later photo revealed spread of erythema in addition to what appears to be small abscess. He c/o of low grade fever 99-101.1 for which he used Paracetamol. Other c/o included headache, nausea without vomiting and right hand numbness. When I spoke to the pt 08/26/15 I told him I would call in a prescription for the skin infection. He will be seen in our office when he returns from out of town 08/28/15. He states all symptoms other are improved over last two days.
Age: 73.0
Sex: M
Vaccine: TDAP
Symptoms: Dyspnoea
Clinical narrative: Pt was having trouble breathing so went to ER.
Age: 68.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Induration, Pain
Clinical narrative: 10X5cm induration, redness, pain.
Age: 51.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Swelling
Clinical narrative: Patient describes developing swelling and a red bump after receiving the Prevnar 13 vaccine.
Age: 48.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Swelling
Clinical narrative: Patient describes developing swelling and a red bump after receiving the Prevnar 13 vaccine.
Age: 56.0
Sex: F
Vaccine: FLU4
Symptoms: Chills, Cough, Fatigue, Headache, Pain
Clinical narrative: Started with upper respiratory infection in lungs with cough leading to headache, chills, body aches, restless legs, sneezing and exhaustion.  Fever started within 32 hours from onset and reached 103.8 degrees.  (Started Azithromycin 250mg 12 hours after onset.)  Fever broke after 84 hours of onset.
Age: 56.0
Sex: F
Vaccine: FLU4
Symptoms: Pyrexia, Restless legs syndrome, Sneezing, Upper respiratory tract infection
Clinical narrative: Started with upper respiratory infection in lungs with cough leading to headache, chills, body aches, restless legs, sneezing and exhaustion.  Fever started within 32 hours from onset and reached 103.8 degrees.  (Started Azithromycin 250mg 12 hours after onset.)  Fever broke after 84 hours of onset.
Age: 30.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Swelling
Clinical narrative: Patient describes developing swelling and a red bump after receiving the Prevnar 13 vaccine.
Age: 34.0
Sex: F
Vaccine: FLU3, TDAP, FLU3, TDAP
Symptoms: Injection site erythema, Injection site nodule, Injection site swelling, Pain in extremity, Pyrexia
Clinical narrative: Patient developed swelling, redness and knot under skin at site of injection. Arm is sore when moved. She thinks she may have a slight fever. Counseled to use ibuprofen and apply ice pack.
Age: 34.0
Sex: F
Vaccine: FLU3, TDAP, FLU3, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: Patient developed swelling, redness and knot under skin at site of injection. Arm is sore when moved. She thinks she may have a slight fever. Counseled to use ibuprofen and apply ice pack.
Sex: F
Vaccine: MEN
Symptoms: Adverse event, Asthma, Dyspnoea, Injection site swelling, Local swelling
Clinical narrative: Based on additional information received on 15 May 2015, this case was initially considered as non-serious was upgraded to serious due to important medical event (Asthma). Initial unsolicited report received from a consumer (patient parent) on 04 August 2015. A female child patient, whose age, medical history and concomitant medications were not reported, had received a dose of Meningococcal vaccine (batch number, dose, dose number, route and site of administration were not reported) on an unspecified date. On unspecified date after vaccination, patient had suffered from adverse effects (not specified). It was also reported that patient had to go for ER/doctor visit. Laboratory investigations and corrective treatments were not reported. At the time of this report, the outcome of event was not reported. Follow up information received from a consumer (patient parent) on 15 August 2015. The patient was vaccinated in the arm. On an unspecified date post vaccination, the patient's limbs began to swell and at the injection site, the arm swelled and spread to her elbow and to the back of her neck. Her legs felt tingly. She had asthma and her mother was worried that her bronchioles could have swelled and caused her difficulty in breathing. It was reported that she took a month to recover from the event of tingling. She had slept a lot however her arm did not feel the same. She had not recovered from the event of limb swelling which began at the injection site and spread to her elbow and to the back of her neck. The outcome for asthma was not provided. Upon medical review, the case was considered as serious due to important medical event: Asthma. Documents held by sender: none.
Sex: F
Vaccine: MEN
Symptoms: Paraesthesia, Peripheral swelling
Clinical narrative: Based on additional information received on 15 May 2015, this case was initially considered as non-serious was upgraded to serious due to important medical event (Asthma). Initial unsolicited report received from a consumer (patient parent) on 04 August 2015. A female child patient, whose age, medical history and concomitant medications were not reported, had received a dose of Meningococcal vaccine (batch number, dose, dose number, route and site of administration were not reported) on an unspecified date. On unspecified date after vaccination, patient had suffered from adverse effects (not specified). It was also reported that patient had to go for ER/doctor visit. Laboratory investigations and corrective treatments were not reported. At the time of this report, the outcome of event was not reported. Follow up information received from a consumer (patient parent) on 15 August 2015. The patient was vaccinated in the arm. On an unspecified date post vaccination, the patient's limbs began to swell and at the injection site, the arm swelled and spread to her elbow and to the back of her neck. Her legs felt tingly. She had asthma and her mother was worried that her bronchioles could have swelled and caused her difficulty in breathing. It was reported that she took a month to recover from the event of tingling. She had slept a lot however her arm did not feel the same. She had not recovered from the event of limb swelling which began at the injection site and spread to her elbow and to the back of her neck. The outcome for asthma was not provided. Upon medical review, the case was considered as serious due to important medical event: Asthma. Documents held by sender: none.
Age: 11.0
Sex: F
Vaccine: FLU3, HPV9, MNQ
Symptoms: Injection site swelling, Injection site warmth
Clinical narrative: Swelling at site and warm to touch of left upper deltoid.
Sex: F
Vaccine: MEN
Symptoms: Drug ineffective, Meningitis meningococcal
Clinical narrative: Initial unsolicited report received from a consumer (patient mother) on 15 August 2015. A female patient, whose age, medical history and concomitant medications were not reported, had received a dose of Meningococcal Vaccine (manufacture: unknown, batch number, route and site of administration were not reported) on unspecified date. On unspecified date, after vaccination as scheduled, the patient came down with less than two years and vaccine did not work. It was reported that parent will not rather expose her children to the ingredients in vaccines if they are going to have potential harm while not even preventing the infection. Laboratory investigations and corrective treatments were not reported. At the time of this report, the outcome of the event was unknown. Upon medical review, the case was considered as serious due to important medical event: meningococcal meningitis. Documents held by sender: none.
Sex: F
Vaccine: TDAP
Symptoms: Activities of daily living impaired, Erythema, Lymph node pain, Lymphadenopathy, Malaise
Clinical narrative: Initial unsolicited report received from a non-healthcare professional on 19 August 2015. A female patient (age not reported), whose medical history and concomitant medications were not reported, had received a dose of ADACEL (batch number U5271AA, dose, route of administration and site of administration were not reported) on an unspecified date. On 17 August 2015, after vaccination, the patient experienced extreme swelling of axilla lymph nodes/swelling and pain redness of lymph node. It was reported that on 17 August 2015 and 18 August 2015, the patient was "called in sick" due to swelling and pain. On 19 August 2015, the patient still had extreme swelling of axilla lymph nodes. The patient did not experienced redness of lymph node. Laboratory investigations and corrective treatments were not reported. At the time of this report, the outcome of events was not reported. Upon medical review, the case was considered as serious due to important medical event: axillary lymphadenitis and feeling sick. Documents held by sender: none.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Urticaria
Clinical narrative: Hives behind knees and on elbows.
Age: 22.0
Sex: F
Vaccine: HEP, VARCEL
Symptoms: Rash, Varicella
Clinical narrative: Patient developed a rash and saw a physician who dx varicella.
Age: 80.0
Sex: M
Vaccine: PNC13, PPV
Symptoms: Arthralgia, Blood creatine phosphokinase normal, Full blood count normal, Metabolic function test normal, Myalgia
Clinical narrative: Myalgias and arthralgias throughout body.  Has lasted at least to the 24th. There were still ongoing.
Age: 80.0
Sex: M
Vaccine: PNC13, PPV
Symptoms: Myoglobin urine absent, Red blood cell sedimentation rate normal
Clinical narrative: Myalgias and arthralgias throughout body.  Has lasted at least to the 24th. There were still ongoing.
Age: 80.0
Sex: M
Vaccine: PNC13, PPV
Symptoms: Activities of daily living impaired, Blood test normal, Insomnia, Myalgia, Pyrexia
Clinical narrative: Myalgias and arthralgias throughout body.  Has lasted at least to the 24th. There were still ongoing.
Age: 80.0
Sex: M
Vaccine: PNC13, PPV
Symptoms: Respiratory tract congestion
Clinical narrative: Myalgias and arthralgias throughout body.  Has lasted at least to the 24th. There were still ongoing.
Age: 2.0
Sex: M
Vaccine: DTAPIPV, HEPA, PNC13
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: NONE.
Age: 21.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Chills, Pyrexia
Clinical narrative: Fever and chills. Temp @ 104 at the clinic @ 0915 today.
Age: 10.0
Sex: M
Vaccine: RAB
Symptoms: Arthralgia, CSF test normal, Dizziness, Headache, Pyrexia
Clinical narrative: Fever, headache, dizziness, and diffuse joint pains x 1 day, responsive to Motrin.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Patient had severe arm pain, could hardley move arm.  Slightly better today, still difficult to move.  Pt went to MD, used Motrin and hot and cold packs for pain.
Age: 68.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site pruritus
Clinical narrative: Patient states that she began to feel itchiness near vaccination site.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Arthralgia, Headache, Myalgia, Pyrexia
Clinical narrative: Fever, headaches, joint and muscle pain for 3 days.
Age: 15.0
Sex: F
Vaccine: HPV4, MENB
Symptoms: Arthralgia, Headache, Myalgia, Pyrexia
Clinical narrative: Fever, headache, joint and muscle pain for 3 days.
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Arthralgia, Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Fever, chills, headache, joint and muscle pain.
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: Patient came to pharmacy on 08/25/2015 and complained that after she received her vaccination her arm became red and swollen and was hot to the touch. She did not seek medical attention nor did she contact us at the pharmacy until 5 weeks after the receiving the vaccine.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Cellulitis
Clinical narrative: Within 48 hours patient developed cellulitis in the arm of shingles vaccine administration. The patient went to the Doctor and was prescribed two antibiotics in order to clear the cellulitis.
Age: 0.01
Sex: M
Vaccine: HEP
Symptoms: Hypotonia
Clinical narrative: Vaccine given at 11:51 AM and within 2 hrs patient had limp upper and lower extremities lasting for 12 hrs.  He was feeding and breathing normally and had no fevers.  After 12 hrs, he went back to normal.
Age: 28.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Peripheral swelling, Skin warm, Staphylococcal infection
Clinical narrative: Patient stated she went to the ER about 4-5 days after she got the vaccine.  She said her arm was red, swollen, hot to the touch.  She said the ER said she had a staph infection and they placed her on antibiotics.  She went to other pharmacy today (8/26/15) and got her second Varivax dose in the other arm.
Age: 1.57
Sex: M
Vaccine: HEPA
Symptoms: Rash, Rash erythematous
Clinical narrative: Fine red bumps on trunk. No fever, eating well, playful.
Age: 3.0
Sex: M
Vaccine: DTAP, MMRV
Symptoms: Pyrexia
Clinical narrative: Fever developed with highest reading at 103.2. Fever has persisted the last 9 days.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Dyskinesia, Eye movement disorder, Loss of consciousness
Clinical narrative: Passed out, eyes rolled back in head while head jerking.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Feeling hot, Flushing, Hypoaesthesia, Pain in extremity
Clinical narrative: Full body flushing, small rashes/possibly hives on chest, full body itching, feeling of warmth, arm soreness, hand numbness on injection site side, red colored chest/neck (Benadryl and ibuprofen taken).
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus generalised, Rash
Clinical narrative: Full body flushing, small rashes/possibly hives on chest, full body itching, feeling of warmth, arm soreness, hand numbness on injection site side, red colored chest/neck (Benadryl and ibuprofen taken).
Age: 2.0
Sex: F
Vaccine: HEPA
Symptoms: Blood culture negative, Culture throat negative, Full blood count normal, Generalised tonic-clonic seizure, Metabolic function test normal
Clinical narrative: Approx 4.5 to several hours after vaccine given patient developed fever to 102 F and had 3 brief GTC seizures.
Age: 2.0
Sex: F
Vaccine: HEPA
Symptoms: Pyrexia, Streptococcus test negative
Clinical narrative: Approx 4.5 to several hours after vaccine given patient developed fever to 102 F and had 3 brief GTC seizures.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV9, MNQ, TDAP
Symptoms: Erythema, Hypersensitivity, Injection site reaction, Pruritus, Swelling
Clinical narrative: 8/13/15 at 12:22 p.m. pt and mother noticed redness, swelling and itching the size of quarter. 8/14/15 at 0908 mother describes the redness has increased to the size of an adult fist. Pt sought medical care at local urgent care who states this was allergic reaction to Tdap. (Lt) upper thigh.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Enema administration, Intussusception, Surgery
Clinical narrative: Pt seen in office evening of 8/25/15. Worsened. Seen in ER later that night and diagnosed with intussusception. Air enema x 2 - not resolved. Surgery done to reverse problem.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to multiple patients of unknown age and gender. On an unknown date the patients were vaccinated with PROQUAD (Merck) lot # K022445, with expiry date 13-MAY-2016 and lot # L013545, with expiry date 17-OCT-2015, that was improperly stored. No other adverse effects were reported. The outcome of the improper storage of vaccine was not known. This is one of the two reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a healthcare worker (also a medical assistant) referring to an unspecified number of patients of unknown age and gender. There was no medical history or drug reaction/allergies reported. On unknown dates the patients was vaccinated with doses of improperly stored GARDASIL (lot # K011325 with expired date 08-APR-2017, dose and route were unknown). No concomitant medication was provided. No adverse effects were reported. This was one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to multiple patients of unknown age and gender. On an unknown date, the patients were vaccinated with (Oka/Merck) VARIVAX lot # K009756 and K009758, with expiry date 09-JUL-2016, that was improperly stored. No adverse effects were reported. The outcome of the improper storage of vaccine was not known. This is one of two reports received from the same source. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEP, HEPA, HIBV, MMRV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: This spontaneous report was received from a consumer (Patient's mother) refers to her daughter who is 4 year old. Patient's mother stated that her daughter, at the age of 12 months received an unspecified vaccination of measles and varicella. On 16-JUL-2015 at the age of 4 years, patient was vaccinated with PROQUAD (Merck). On 21-AUG-2015 the patient was vaccinated with second dose of PROQUAD (Merck) (strength not reported) 0.5 ml subcutaneous injection with a lot # L009210 (expiry date not provided). Concomitant therapies included DTAP-IPV, Hepatitis A vaccine, Hepatitis B vaccine and Hib Conj vaccine (unspecified carrier). No adverse events were reported. There was no product quality complaint involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information was received from a healthcare worker referring to a patient of unknown age and gender. The patient's medical history and concurrent condition were not reported. On 20-AUG-2015 the patient was vaccinated with a dose of improperly stored VARIVAX (Merck) (dose number, dose and route unknown, lot # L007225, expiration date: 03-MAR-2017). There was no information about concomitant therapy. No adverse event was reported. Additional information has been requested.
Age: 41.0
Sex: U
Vaccine: VARCEL
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report as received from a certified medical assistant (C.M.A.) refers to a 40 year old patient of unknown gender. The patient's medical history and drug reactions or allergies were not provided. On 24-AUG--2015 (reported as today), the patient was vaccinated with a second dose of expired (Oka/Merck) VARIVAX (0.5 ml, subcutaneous in the left arm, lot# reported as J006357, expiration date 23-MAY-2015). The first dose of (Oka/Merck) VARIVAX was administered on 20-APR-2015. No adverse events were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Injection site induration, Pruritus, Skin warm, Swelling
Clinical narrative: Abnormal swelling and erythema. Erythema measuring 16cm with a 4cm area of induration located around MENACTRA site. Erythematous area is hot to the touch. Patient c/o pruritus and tenderness to palpation.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Tenderness
Clinical narrative: Abnormal swelling and erythema. Erythema measuring 16cm with a 4cm area of induration located around MENACTRA site. Erythematous area is hot to the touch. Patient c/o pruritus and tenderness to palpation.
Age: 87.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site induration, Injection site nodule, Pyrexia
Clinical narrative: Redness at site of injection, hard knot low grade fever-required MD visit. Late onset of reaction indicates possible allergy to drug.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Abdominal pain, Chest X-ray abnormal, Dizziness, Lung infiltration, Pneumonia
Clinical narrative: Few hours after getting shots he was dizzy and had fever of 103.2 and abdominal pain. Fever persisted for several days. He was seen in ER 8/24 and diagnosed with pneumonia.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Pyrexia
Clinical narrative: Few hours after getting shots he was dizzy and had fever of 103.2 and abdominal pain. Fever persisted for several days. He was seen in ER 8/24 and diagnosed with pneumonia.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Tremor
Clinical narrative: 3 hours after 2mo vaccines, pt had a "shaking" episode. Started in (R) leg and progressed to the entire body. Symptoms lasted for a few seconds. No other symptoms reported.
Age: 0.42
Sex: M
Vaccine: DTAPIPV
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: 5 month old male given KINRIX. Phone calls and message made to parents and emergency contact with no response, to inquire about adverse events.
Age: 74.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema
Clinical narrative: Redness at injection site.
Age: 22.0
Sex: M
Vaccine: HEPA
Symptoms: Dizziness, Dry mouth, Eye irritation, Eye pain, Nausea
Clinical narrative: Dizziness, nausea, eyes stinging, increased pain in arm, eyes burning, dry mouth, felt like going to "pass out".
Age: 22.0
Sex: M
Vaccine: HEPA
Symptoms: Pain in extremity
Clinical narrative: Dizziness, nausea, eyes stinging, increased pain in arm, eyes burning, dry mouth, felt like going to "pass out".
Age: 11.0
Sex: F
Vaccine: TDAP
Symptoms: Dehydration, Headache, Pain, Pyrexia, Vomiting
Clinical narrative: 102 degree F fever, vomiting x 3-4, headache, pain throughout body, dehydration.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site rash, Local reaction
Clinical narrative: Local reaction with 2 bumps and redness to injection area x 2 wks. Treated with antibiotic ointment, oral BENADRYL, and oral ibuprofen.
Age: 36.0
Sex: F
Vaccine: HEP
Symptoms: Injection site hypersensitivity, Injection site reaction, Urticaria
Clinical narrative: Evening after receiving vaccine noticed welts on (L) upper arm approximately 2" below injection site. By next day had 5 more welts on (L) upper arm. 3 days later had 18 welts. Saw her PCP, who said it seemed to be an allergic reaction. One week out now welts just beginning to subside.
Age: 0.34
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Pyrexia
Clinical narrative: 104 fever after immunizations for 1 1/2 days.
Age: 4.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR, PNC13
Symptoms: Rash
Clinical narrative: Rashes on the face, back, body and extremities started 24 hrs from vaccination relieve Kw/ BENADRYL slowly. Still have rashes on the palms as of today.
Age: 1.01
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Erythema multiforme, Purpura, Urticaria
Clinical narrative: Erythema multifore reaction - hive-like lesions w/mild purpura on extremities mainly 13 days post vaccination.
Age: 6.0
Sex: F
Vaccine: DTAP, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Approx. 24 hours after receiving vaccines, child developed a red spot on (L) outer thigh that increased in size, was painful to touch. Symptoms child care to be evaluated 8/26/15. No tx needed.
Age: 1.08
Sex: F
Vaccine: DTAPIPV, MMR, PNC13, VARCEL
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Pt. was 13 months old and here for 12 mo WCC on 4-30-15. KINRIX was given. CDC states that the DTaP can count as 4th dose if minimal interval had passed and there was 6 months between 3rd and 4th DTaP (KINRIX).
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: (L) thigh-10 x 14 cm red, warm area, now tender.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Abscess limb, Culture, Swelling
Clinical narrative: Thigh abscess 8 days following vaccine. Swelling and fluctuance. TX with clindamycin x 10 days.
Age: 73.0
Sex: F
Vaccine: PNC13
Symptoms: Hypoaesthesia oral, Middle insomnia
Clinical narrative: Received immunization on 8/17/15 at approximately noon. About 2am, she woke up and the right side of her tongue was numb. The numbness lasted for about 8 hours and she has been fine since.
Age: 5.0
Sex: F
Vaccine: HEPA, PNC13
Symptoms: Injection site rash, Injection site urticaria
Clinical narrative: Ras on right inner thigh, and hives. Treated with liquid BENADRY, called in epi pen jr. Appointment with the allergist.
Age: 0.5
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Injection site swelling
Clinical narrative: Swollen leg after PREVNAR 13 vaccine given in right thigh gave 2 ml of BENADRYL after 15 min, reaction cleared.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Peripheral swelling
Clinical narrative: 8/25/15 at 3:30 pm swelling noticed. Swelling and redness notice on both arms. Treatment: Ice, rest, ibuprofen.
Age: 0.53
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Onset 9:15-9:30 AM redness, induration and hot to touch at immunization site (right thigh).
Age: 2.0
Sex: M
Vaccine: DTAPIPVHIB, HEPA
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Crying, Staring, Unresponsive to stimuli
Clinical narrative: Immunized at 1:50 pm. Was crying prior to immunizations, cried a few minutes after immunizations, put in car seat. At 2:00 pm, in car, child staring and non-responsive to stimuli x 1 min. Then child normal. Took to pediatrician on 8/26. No unusual symptoms.
Age: 55.0
Sex: M
Vaccine: DT, PPV
Symptoms: Erythema, Rash, Swelling
Clinical narrative: Skin Rash and swollen, redness
Age: 18.0
Sex: F
Vaccine: HEP
Symptoms: Skin discomfort
Clinical narrative: Pt states felt like fiberglass under skin when given her last Hep B.
Age: 61.0
Sex: F
Vaccine: TDAP
Symptoms: Abdominal pain upper, Activities of daily living impaired, Diarrhoea
Clinical narrative: Per phone note written on 7/15/11; About 3 days after my injection I had terrible stomach pains and diarrhea I could not control. I finally ended up taking IMMODIUM to control the diarrhea so that I could function through my daily routine.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a healthcare worker, certified medical assistant (CMA) who reported that multiple unspecified patients received doses of improperly stored RECOMBIVAX HB (lot # K007263 expiration date 09-JUN-2016, therapy type unknown, dose, frequency and route were not reported). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HIBV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a healthcare worker (also a medical assistant) referring to an unspecified number of patients of unknown age and gender. There was no medical history or drug reaction/allergies reported. On unknown dates the patients was vaccinated with doses of improperly stored PEDVAXHIB (lot # L004740 with expired date 16-NOV-2017, dose and route were unknown). No concomitant medication was provided. No adverse effects were reported. This was one of several reports received from the same reporter. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: VARZOS, MNQ, TDAP, VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Informatino has been received from a healthcare worker referring to an 11 year old male patient. On 24-AUG-2015 the patient was inadvertently vaccinated with ZOSTAVAX instead of VARIVAX (Merck) (Wrong drug administered). No adverse effects reported. The outcome was unknown. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: VARZOS, MNQ, TDAP, VARZOS
Symptoms: Discomfort, Injection site cellulitis, Injection site erythema, Injection site reaction, Injection site swelling
Clinical narrative: Informatino has been received from a healthcare worker referring to an 11 year old male patient. On 24-AUG-2015 the patient was inadvertently vaccinated with ZOSTAVAX instead of VARIVAX (Merck) (Wrong drug administered). No adverse effects reported. The outcome was unknown. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: VARZOS, MNQ, TDAP, VARZOS
Symptoms: Injection site warmth, Peak expiratory flow rate, Skin lesion, Wrong drug administered
Clinical narrative: Informatino has been received from a healthcare worker referring to an 11 year old male patient. On 24-AUG-2015 the patient was inadvertently vaccinated with ZOSTAVAX instead of VARIVAX (Merck) (Wrong drug administered). No adverse effects reported. The outcome was unknown. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: PPV
Symptoms: Blood culture negative, Culture urine negative, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a pharmacist referring to a 22 year old female patient. The patient was a chronic every day cigarette smoker and she was allergic to cephalosporins and penicillins (reaction unspecified). The patient was hospitalized on an unknown date for an uncomplicated vaginal delivery on 06-AUG-2015. On 07-AUG-2015, first day postpartum, the patient was vaccinated with a dose of PNEUMOVAX23 injection (lot #, dose and route were not reported) by an unspecified healthcare provider. There were no concomitant therapies. On 07-AUG-2015, the patient experienced a fever of 102.9F with redness, warmth, and swelling at the unspecified injection site within 12 hours of receiving the vaccine. A blood and urine culture was taken on an unknown date in August 2015 and both cultures came back negative. The patient was treated with the antibiotics gentamycin and clindamycin. The events improved with antibiotic treatment on an unspecified date and the patient recovered from the events on an unknown date in August 2015. The patient was discharged at the normal length of stay on an unknown date in August 2015 for the uncomplicated vaginal delivery (length of stay and discharge date was unspecified). This is one of several reports received from the same reporter. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: PPV
Symptoms: Pyrexia
Clinical narrative: Information has been received from a pharmacist referring to a 22 year old female patient. The patient was a chronic every day cigarette smoker and she was allergic to cephalosporins and penicillins (reaction unspecified). The patient was hospitalized on an unknown date for an uncomplicated vaginal delivery on 06-AUG-2015. On 07-AUG-2015, first day postpartum, the patient was vaccinated with a dose of PNEUMOVAX23 injection (lot #, dose and route were not reported) by an unspecified healthcare provider. There were no concomitant therapies. On 07-AUG-2015, the patient experienced a fever of 102.9F with redness, warmth, and swelling at the unspecified injection site within 12 hours of receiving the vaccine. A blood and urine culture was taken on an unknown date in August 2015 and both cultures came back negative. The patient was treated with the antibiotics gentamycin and clindamycin. The events improved with antibiotic treatment on an unspecified date and the patient recovered from the events on an unknown date in August 2015. The patient was discharged at the normal length of stay on an unknown date in August 2015 for the uncomplicated vaginal delivery (length of stay and discharge date was unspecified). This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unkonwn age and gender. The patient's medical history and current conditions were not provided. On 20-AUG-2015, the patient was vaccinated with a dose of improperly stored PROQUAD (Merck) (strength, dose and frequency were not reported) lot # L008355, expiration date 11-SEP-2015. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unkonwn date, the patients were vaccinated with doses of PROQUAD (Merck) (Lot # L005295 exp date 17-AUG-2016) (dose and route not reported). No adverse effects were reported. Additional information is not expected as the reporter did not wish further contact.
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Red, swollen left arm from deltoid down to elbow.